Testosterone stabilisation in transdermal devices

Details for Australian Patent Application No. 2006329751 (hide)

Owner Pierre Fabre Medicament

Inventors Sournac, Michel; Bougaret, Joel

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2006329751

PCT Pub. Number WO2007/074239

Priority 0513435 29.12.05 FR

Filing date 26 December 2006

Wipo publication date 5 July 2007

International Classifications

A61J 1/00 (2006.01) Containers specially adapted for medical or pharmaceutical purposes

A61K 31/568 (2006.01) - substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstane, testosterone

B65D 81/26 (2006.01) Containers, packaging elements, or packages, of special types or forms or specially adapted for organisms, articles, or materials presenting particular transport, storage, or dispensing problems - with provision for draining away, or absorbing, fluids, e.g. exuded by contents

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/074239 Priority application(s): WO2007/074239

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006329759-Device for monitoring a product degradation

2006329724-Protection of plants against their pathogenic agents